Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Macomics Announces Appointment of Simon Dew as New Chief Business Officer
-
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
-
DFDS DIVESTS OSLO CRUISE FERRY ROUTE TO ENHANCE TRANSPORT FOCUS
-
Transactions in connection with share buyback programme
-
DFDS to sell Oslo-Frederikshavn-Copenhagen route to Gotlandsbolaget
-
Flash News: OKX Announces Launch of Fixed Simple Earn and VIP Loan
-
Alm. Brand A/S – Weekly report on share buybacks
-
Flash News: OKX Wallet Now Supports Full Force
-
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
-
Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
-
Share buy-back programme - week 23
-
Anmodning om suspension i enkelte afdelinger under Investeringsforeningen Danske Invest
-
Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
-
Virginie Leroy joins VINCI’s Executive Committee
-
Preliminary data on early redemptions (prepayments)
-
The sales of VILVI GROUP May 2024
-
Share repurchase programme
-
Quantexa Debuts Q Assist, New Context Aware Generative AI Technology Suite
-
-
The ECB has issued permission for Laura Križinauskienė to start taking the position of a member of the Management Board of Šiaulių Bankas
-
Exor Press Release - Periodic Report on the Buyback Program
-
Blueshift Named Market Leader in Research In Action's 2024 Vendor Selection Matrix™ Report for Customer Data Management
-
Regenx Rights Offering Fully Subscribed
-
Distributor Orders Nexstim NBS System 5 for European Hospital
-
Subsea7 share repurchases
-
Shell plc First Quarter 2024 Euro and GBP Equivalent Dividend Payments
-
-
Transaction in Own Shares
-
Fingerprint Cards AB (publ) will present at Aktiedagarna in Stockholm on June 12, 2024
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Viridien launches new brand to accelerate growth as an advanced technology company
-
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
-
Start of Day Message
-
IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
-
Santhera Announces Launch of Early Access Program in China for AGAMREE® by its Partner Sperogenix
-
Corbion reports the progress of its € 20 million share buyback program 3 June – 7 June 2024
-
European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer
-
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
-
Food Logistics Names Covenant Logistics Group as Recipient of 2024 Top 3PL & Cold Storage Providers Award
-
Griffin Global Asset Management Extends and Upsizes Senior Unsecured Revolving Credit Facility to $1.2 Billion
-
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
-
REPEAT – EnviroGold Global Closes First Tranche of Private Placement
-
Midnight Gaming Corporation and Compass Arena Chicago, Complete Transformative Booking Services Agreement
-
Optimove Insights Releases the 2024 Consumer Summer Shopping Report
-
ValueZone Anticipates Ethereum Surge as ETFs Expected to Drive $4B Inflows
-
How to Choose the Best Crypto Staking Platform: Insights from StakingFarm
-
Flash News: OKX Wallet Now Supports Copra Fixed-Yield Protocol Debt Marketplace
-
Flash News: OKX Wallet Now Supports Echelon
-
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical T
